Clinical Trial Detail

NCT ID NCT04007744
Title Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Mayo Clinic
Indications

pancreatic adenocarcinoma

transitional cell carcinoma

Advanced Solid Tumor

gastroesophageal junction adenocarcinoma

head and neck squamous cell carcinoma

melanoma

gastric adenocarcinoma

lung non-small cell carcinoma

Therapies

Pembrolizumab + Sonidegib

Age Groups: adult senior

No variant requirements are available.